Metformin Disappoints in Two Phase 2 Lung Cancer Trials ...Middle East

Although well tolerated, metformin did not improve survival when given alongside chemoradiotherapy to patients with locally advanced non-small cell lung cancer (NSCLC). Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Metformin Disappoints in Two Phase 2 Lung Cancer Trials )

Also on site :

• ‘This is about more than burgers and fries’: Boycott of McDonald’s to begin this week
• Trump announces Iran and Israel have agreed to a “Complete and Total CEASEFIRE"
• Royals Option Kyle Wright